EGFR and glioma: According to updated 5th WHO classification of CNS tumors, some wildtype gliomas (with TERT promoter mutation or EGFR gene amplification or + 7/− 10 chromosome copy number changes), that were classified as °II and °III before are now considered as “molecular” glioblastoma.